Prostate cancer often earns the label “silent killer” because it can develop and progress for years without producing noticeable symptoms. Understanding this timeline becomes crucial for men seeking to protect their health through informed decision ...

There is no single, diagnostic test. Doctors make a diagnosis based on various measures. This can include a prostate-specific antigen (PSA) blood test and a scan, as well as a biopsy, which involves taking a small tissue sample to examine in the laboratory.

As a physician, researcher, and biotech leader with personal experience of prostate cancer in my family, I’ve long advocated for putting patients first in our quest for medical innovation. Today, I believe we need to adopt this approach to address an ...

PSA is a validated FDA-recognized clinical endpoint in assessing prostate cancer treatment response; Telomir-1 lowered PSA levels in a dose-related manner.

I’m sharing this information for educational purposes and not for sympathy,” the pop culture critic said. Pop culture critic and

A new study has uncovered promising therapeutic strategies against one of the deadliest forms of prostate cancer.

John Tesh was diagnosed with prostate cancer despite having a low PSA and given 18 months to live back in 2015. Now, 10 years later, here's his his journey since then.

Roswell Park Comprehensive Cancer Center has unveiled the new EDDY Mobile Breast & Prostate Cancer Screening Center, addressing early detection for the three most common invasive cancers.

The Uganda Cancer Institute (UCI) has sounded an urgent warning over a sharp rise in prostate cancer cases, now the most commonly diagnosed cancer among men in the country and a leading cause of cancer-related deaths.